China Pharma Holdings (CPHI) Inventory (2010 - 2026)

China Pharma Holdings (CPHI) has reported Inventory for 17 consecutive years, with $2.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory fell 5.86% year-over-year to $2.5 million; the trailing twelve-month figure through Jun 2026 stood at $2.5 million (down 5.86% YoY), and the FY2025 full-year result was $2.8 million, down 2.59% from the prior year.
• Inventory retreated to $2.5 million in Q2 2026 per CPHI's latest filing, from $2.6 million in the prior quarter.
• Across five years, Inventory topped out at $3.9 million in Q2 2023 and bottomed at $2.5 million in Q3 2024.
• Historically, Inventory has averaged $3.1 million across 5 years, with a median of $2.9 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Inventory soared 31.01% in 2023, then slumped 33.66% in 2024.
• Over 5 years, Inventory stood at $2.9 million in 2022, then jumped by 31.01% to $3.9 million in 2023, then fell by 26.46% to $2.8 million in 2024, then dropped by 2.59% to $2.8 million in 2025, then fell by 8.82% to $2.5 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $2.5 million, $2.6 million, and $2.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.